What is the duration of action of Reglan (Metoclopramide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Action of Reglan (Metoclopramide)

The pharmacological effects of metoclopramide persist for 1 to 2 hours after administration, regardless of route. 1

Pharmacokinetic Profile

The duration of action is distinctly shorter than the elimination half-life, which is an important clinical consideration:

  • Pharmacological effect duration: 1-2 hours after any route of administration 1
  • Elimination half-life: 5-6 hours in patients with normal renal function 1
  • This discrepancy means the drug remains in the body longer than its therapeutic effects last, which has implications for dosing frequency and adverse effect risk 1

Onset of Action by Route

The onset varies significantly by administration route 1:

  • Intravenous: 1-3 minutes
  • Intramuscular: 10-15 minutes
  • Oral: 30-60 minutes

Clinical Implications for Dosing

Standard dosing reflects the short duration of action 2:

  • For diabetic gastroparesis: 5-10 mg orally four times daily (QID), administered 30 minutes before meals and at bedtime 2
  • For intractable hiccups: 10 mg orally three to four times daily 2
  • The four-times-daily dosing schedule is necessary because the 1-2 hour duration of pharmacological effect requires frequent redosing to maintain therapeutic benefit 1

Important Safety Considerations

Despite the short duration of therapeutic action, metoclopramide is generally not intended for long-term use 3:

  • Oral preparations are recommended for only 4-12 weeks of therapy 3
  • Parenteral metoclopramide should be limited to 1-2 days of use 3
  • Extrapyramidal symptoms can occur even with short-term, low-dose treatment and may persist for months after discontinuation 4
  • Monitor for extrapyramidal symptoms (dystonic reactions, akathisia, tardive dyskinesia), especially with high doses or prolonged use 2

Renal Impairment Effects

Renal dysfunction significantly prolongs the elimination half-life but does not change the 1-2 hour duration of pharmacological action 1:

  • Clearance is reduced in renal impairment, requiring downward dose adjustment to avoid drug accumulation 1
  • The kinetics remain linear even in renal impairment 1

References

Guideline

Metoclopramide Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metoclopramide: a dopamine receptor antagonist.

American family physician, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.